We hypothesised that having a history of obesity (having been overweight but subsequently losing weight) may result in residual defects in insulin action, particularly in adipose tissue, and ultimately may contribute to worse metabolic outcomes upon weight regain. This evidence concerns the gene INS and obesity disorder.